More Activists Urge Johnson & Johnson to Break Up

Johnson & Johnson (NYSE:JNJ), the largest drug maker globally, could be expected to consider splitting itself up. Activists are said to be urging the drug maker to consider the option, as the estimated combined value of Johnson & Johnson's three businesses is greater than the company’s current individual value.

The behemoth drug maker is split into three main divisions – consumer care, pharmaceuticals and medical devices.

Back to news